Skip to content
Home/Companies/Pharma/Egalet

Egalet

Pharma·Denmark·Exited 2014·Held 4yr
Entry
2010
Hold
4yr
Exit
2014

Who owns Egalet?

Egalet was owned by Sunstone Life Science Ventures through Sunstone Life Science Ventures III (2007 vintage) from 2010 to 2014, exited via IPO.

Hand-verified · updated 2026-08-18

Sunstone Life Science Ventures
Investor
Sunstone Life Science Ventures
Sunstone Life Science Ventures III · 2007 · VC

Key facts

HQDenmark
SectorPharma
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2014

More from Sunstone Life Science Ventures III

Other portfolio companies in the same fund.

MinervaX
MinervaX
Active
BiotechDenmark· 2014
Cantargia
Exited 2015
BiotechSweden· 2013
Opsona Therapeutics
Exited 2019
BiotechIreland· 2013
Follicum
Exited 2014
BiotechSweden· 2012
to
Galecto
Exited 2020
BiotechDenmark· 2012
Orphazyme
Orphazyme
Exited 2017
BiotechDenmark· 2011

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Egalet

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Egalet?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Egalet.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue